ArticleJournal of medical virology2021

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients.

Areej Mohamed Ateya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.